Skip to main content
. 2014 Dec 23;15(12):1688–1699. doi: 10.4161/15384047.2014.972799

Table 2.

The EC50 values of the indicated cell lines treated with the indicated compounds over 48 hours, *28 hours, **24 hours

EC50 (μM) Maritoclax KS04 KS17 KS18 KS19 KS20 KS24 ABT-737 Daunorubicin
K562/Mcl-1-IRES-Bim 0.99 1.41 1.13 0.60* 0.41 0.55 0.58 9.3**  
K562/Bcl-2-IRES-Bim >20 >25 >20 >50*       0.35**  
Jurkat 2.53 2.97   1.15 1.21 1.68   0.66  
JurkatΔBak >15 >20   >25 >25 >25   >50  
HL60/VCR 1.67 1.35 1.17 0.69 0.66 0.71   >50 30.41
HL60/ABTR 2.15 3.03 1.63 0.73 0.80 0.83 1.83 >100 12.17
Kasumi-1 1.80 6.70   1.47       0.01  
Kasumi-1/ABT 2.15 2.91   0.70       0.51 0.46
THP-1 6.31 3.74   1.96       1.27 0.065
U937 1.23 1.66 1.77 0.54 0.50 0.67 0.57 5.29 0.86
C1498 1.66 1.12   0.70 0.85 0.68   6.13 1.92
RPMI 8226 2.68 1.87 0.94 0.72 0.58 0.57   0.25 0.23
MM.1S 3.72 1.92 1.71 0.79 0.68 0.69   0.40 0.12
NCI-H929 1.47 1.00 1.30 0.72 0.74 0.73   15.21 0.24
U266 2.15 2.04   0.90       0.68